Campus
Berlin Buch

In Berlin Buch, Charité is part of the biotechnology park and thus one of the largest biomedical centers in Germany. We are planning a range of new research projects here.

As part of the biotechnology park, Charité operates several clinical research facilities and promotes translation at Campus Berlin Buch in northeast Berlin. The biotechnology park provides laboratory and research areas for over 60 biomedicine and biotechnology companies and start-ups. As such, it is perfectly suited to Charité’s application-oriented approach.

Driving force for science

Together with the Max-Delbrück-Center for Molecular Medicine (MDC) and the Leibniz Research Institute for Molecular Pharmacology (FMP), the university hospital wants to promote translation. Together with the MDC, Charité operates the translational Experimental and Clinical Research Center (ECRC) on campus, for example. Through clinical studies, the ECRC is investigating the development of neurological and metabolic diseases. They also research cardiovascular diseases, cancer and methods for putting the findings directly to practice.

The ECRC includes a growing number of higher education outpatient clinics with specialised consultancy for patients, an environment specifically designed for clinical research and state-of-the-art technology in imaging procedures, for example.

Building for research and translation

Various construction projects for research purposes are part of the vision for the future of Campus Berlin Buch. Here is a selection:

• Together with the MDC, a new building for cryoelectronic microscopy is planned. The Berlin Institute of Health at Charité (BIH@Charité) at Charité is establishing a new research focus in vascular medicine in close cooperation with the ECRC. This area is becoming increasingly important in times of demographic change. Additional research areas are being created in close cooperation with Charité. 

• Charité is also planning to expand cross-discipline university outpatient clinics. This applies in particular to the specialist areas of vascular medicine, metabolism and cancer.

• The new Käthe Beutler Building research building has just been completed – a joint project with the Berlin Institute of Health at Charité (BIH@Charité) and the Max-Delbrück-Center for Molecular Medicine (MDC). On the former site of two 1970s buildings, researchers are now developing new personalised therapies for chronic diseases over an area of around 2,500 square metres of floor space in laboratories, offices and communication zones.